These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 15521974

  • 1. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP.
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D, Umans-Eckenhausen MA, Marks D, Defesche JC, Kastelein JJ, Thorogood M.
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Screening for familial hypercholesterolaemia.
    Bender R, Bell DA, Hooper AJ, Edwards G, van Bockxmeer FM, Watts GF, Burnett JR.
    Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
    [Abstract] [Full Text] [Related]

  • 9. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC, Roe MT, Fraulo ES, Peterson ED, Ballantyne CM, Genest J, Gidding SS, Hammond E, Hemphill LC, Hudgins LC, Kindt I, Moriarty PM, Ross J, Underberg JA, Watson K, Pickhardt D, Rader DJ, Wilemon K, Knowles JW.
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z, Watts GF, Pang J, Sijbrands EJ, van Bockxmeer FM, O'Leary P, Geelhoed E, Liew D.
    J Clin Lipidol; 2014 Mar; 8(4):390-400. PubMed ID: 25110220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G, Ose L.
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [Abstract] [Full Text] [Related]

  • 17. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES, Jansen AC, de Jongh S, de Sauvage Nolting PR, Kastelein JJ.
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia].
    Oliva J, López-Bastida J, Moreno SG, Mata P, Alonso R.
    Rev Esp Cardiol; 2009 Jan; 62(1):57-65. PubMed ID: 19150015
    [Abstract] [Full Text] [Related]

  • 20. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW, Kastelein JJ, Defesche JC.
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.